Ultragenyx Pharmaceutical (RARE) Revenue Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 122.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.94% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.47% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 54.05% |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | 10.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.61% |
| Dec 31, 2025 | 26.11% |
| Sep 30, 2025 | 20.81% |
| Jun 30, 2025 | 23.06% |
| Mar 31, 2025 | 20.25% |
| Dec 31, 2024 | 25.45% |
| Sep 30, 2024 | 19.55% |
| Jun 30, 2024 | 19.12% |
| Mar 31, 2024 | 3.07% |
| Dec 31, 2023 | 11.57% |
| Sep 30, 2023 | 6.37% |
| Jun 30, 2023 | 20.63% |
| Mar 31, 2023 | 40.40% |
| Dec 31, 2022 | 42.66% |
| Sep 30, 2022 | 52.05% |
| Jun 30, 2022 | 54.66% |
| Mar 31, 2022 | 63.85% |
| Dec 31, 2021 | 72.45% |
| Sep 30, 2021 | 90.75% |
| Jun 30, 2021 | 89.44% |
| Mar 31, 2021 | 110.36% |
| Dec 31, 2020 | 251.94% |
| Sep 30, 2020 | 643.78% |
| Dec 31, 2019 | 1,823.67% |
| Sep 30, 2019 | 514.84% |
| Jun 30, 2019 | 1,024.13% |